By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Biocept, Inc. 

2151 Las Palmas Drive
Suite C
Carlsbad  California  92009  U.S.A.
Phone: 760-804-9580 Fax: 760-804-6238



Company News
Biocept (BIOC) Added To The Russell Microcap Index 6/26/2017 9:50:23 AM
Biocept (BIOC) And MediNcrease Health Plans Announce Provider Agreement Expanding Access To Liquid Biopsy Testing 6/21/2017 11:35:45 AM
Biocept (BIOC) Awarded U.S. Patent With Broad Claims For Antibody Capture Of Targets Of Interest On Any Solid Surface Including Ctcs And Other Materials Shed By Solid Tumors Into Blood 5/22/2017 6:51:21 AM
Biocept (BIOC) Reports First Quarter 2017 Financial Results 5/12/2017 8:33:35 AM
The Addario Lung Cancer Medical Institute And Biocept (BIOC) Announce Collaboration And Initiation Of Landmark ALCMI-009 Liquid Biopsy Clinical Trial In Lung Cancer 5/10/2017 7:37:02 AM
Biocept (BIOC) To Release First Quarter 2017 Financial Results And Host Investor Conference Call On May 11, 2017 5/3/2017 10:30:33 AM
Biocept (BIOC) Awarded Additional Patent In Japan Expanding Intellectual Property Estate To 19 Issued Patents Protecting Its Target Selector Liquid Biopsy Platform 4/18/2017 7:01:30 AM
Biocept (BIOC) Announces Collaboration With The OHSU Knight Cancer Institute To Increase Clinical Adoption Of Liquid Biopsy Testing And To Co-Develop Additional Assay Platform Capabilities 4/3/2017 7:52:59 AM
SoCal's Biocept (BIOC) Rakes in $9.3 Million Financing 3/28/2017 7:28:50 AM
Biocept, Inc. (BIOC) And Catalyst Pharma (CPRX) Collaborate To Provide Liquid Biopsy Testing For Small Cell Lung Cancer To Patients With Lambert Eaton Myasthenic Syndrome (LEMS) 3/14/2017 6:43:10 AM